Identifier | Name |
---|---|
5602389 | Pyogenic bacterial infections in humans with MyD88 deficiency |
9716879 | Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists |
9677938 | Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies |
9634997 | Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds |
2399514 | Pyridinoline, a non-reducible crosslink of collagen. Quantitative determination, distribution, and isolation of a crosslinked peptide |
9634963 | Pyridostigmine in the treatment of orthostatic intolerance |
9635078 | Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience |
109428 | Pyrimidine 5' nucleotidase deficiency |
109434 | Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides |
76627 | Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis |
879199 | Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants |
879210 | Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway |
9686128 | Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages |
9710067 | Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death |
9708407 | Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid |
9646515 | Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma |
9861884 | Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis |
353153 | Pyruvate carboxylase. II. Properties |
353150 | Pyruvate carboxylase. IX. Some properties of the activation by certain acyl derivatives of coenzyme A |
70066 | Pyruvate dehydrogenase E3 binding protein deficiency |
9861585 | Pyruvate dehydrogenase complex deficiency: updating the clinical, metabolic and mutational landscapes in a cohort of Portuguese patients |
9861634 | Pyruvate dehydrogenase deficiency and epilepsy |
210337 | Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP |
9861917 | Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications |
204177 | Pyruvate dehydrogenase phosphatase deficiency: identification of the first mutation in two brothers and restoration of activity by protein complementation |
9861875 | Pyruvate dehydrogenase phosphatase deficiency: orphan disease or an under-diagnosed condition? |
450640 | Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription |
500643 | Q/R site editing controls kainate receptor inhibition by membrane fatty acids |
8953630 | QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology |
8955554 | QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease |
9725705 | QUINETHAZONE, A NEW ORAL DIURETIC |
2076211 | Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization |
110557 | Quality control by DNA repair |
983433 | Quality control of MHC class I maturation |
975934 | Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function |
9839107 | Quality control of mitochondrial protein synthesis is required for membrane integrity and cell fitness |
9840210 | Quality control of the mitochondrial proteome |
9838031 | Quality control of the mitochondrion |
9754973 | Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake |
6806902 | Quantification of cytochrome P450 reductase gene expression in human tissues |
192831 | Quantification of influenza virus messenger RNAs |
9713271 | Quantification of interacting cognate odorants with olfactory receptors in nanovesicles |
9637694 | Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice |
982871 | Quantitating protein synthesis, degradation, and endogenous antigen processing |
4549235 | Quantitating the specificity and selectivity of Gcn5-mediated acetylation of histone H3 |
9671738 | Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation |
9751012 | Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients |
9028465 | Quantitative GTPase Affinity Purification Identifies Rho Family Protein Interaction Partners |
9818265 | Quantitative Phospho-proteomic Analysis of TNFα/NFκB Signaling Reveals a Role for RIPK1 Phosphorylation in Suppressing Necrotic Cell Death |
9716140 | Quantitative Proteomics Identified TTC4 as a TBK1 Interactor and a Positive Regulator of SeV-Induced Innate Immunity |
9759596 | Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies |
1247664 | Quantitative analyses of the CO2 dissociation curve of oxygenated blood and the Haldane effect in human blood |
1248643 | Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma |
9759592 | Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR |
5663051 | Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review |
© 2024 Reactome